Charles Bonnet syndrome: Successful treatment of visual hallucinations due to vision loss with Yi-gan san

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 2, 2009, Pages 382-383

  Miyaoka, Tsuyshi ^a   Nagahama, Michiharu ^a   Tsuchie, Keiko ^a   Hayashida, Maiko ^a   Nishida, Akira ^a   Inagaki, Takuji ^a   Horiguchi, Jun ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; UNCLASSIFIED DRUG; YI GAN SAN;

AGED; BRAIN BLOOD FLOW; CASE REPORT; CHARLES BONNET SYNDROME; COGNITION; COGNITIVE DEFECT; ELECTROENCEPHALOGRAM; FEAR; FEMALE; HUMAN; LETTER; MINI MENTAL STATE EXAMINATION; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; RETINA IMAGE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UNSPECIFIED SIDE EFFECT; VISION; VISUAL ACUITY; VISUAL FIELD; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

AGED; DRUGS, CHINESE HERBAL; ELECTROENCEPHALOGRAPHY; FEMALE; HALLUCINATIONS; HUMANS; MACULAR DEGENERATION; MAGNETIC RESONANCE IMAGING; SYNDROME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VISION DISORDERS;

EID: 60049090430     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.12.005     Document Type: Letter

References (14)

1. Aizawa R., Kanbayashi T., Saito Y., Ogawa Y., Sugiuama T., Kaneko T., et al. Effect of yoku-kan-san-ka-chinpi-hange on the sleep of normal healthy adult subjects. Psychiatry Clin Neurosci 56 (2002) 303-304
2. Ashwin P.T., and Tsaloumas M.D. Complex visual hallucinations (Charles Bonnet syndrome) in the hemianopic visual field following occipital infarction. J Neurol Sci 263 (2007) 184-186
3. Iwasaki K., Satoh-Nakagawa T., and Maruyama M. A randomized observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 66 (2005) 248-252
4. Liao F.F., Jan Y.M., and Huang S.Y. Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drug. Proc Natl Sci Counc Repub China B 19 (1955) 151-158
5. Menon G.J. Complex visual hallucinations in the visually impaired. Arch Ophtalmol 123 (2005) 349-355
6. Miyaoka T., Furuya M., Yasuda H., Hayashida M., Inagaki T., and Horiguchi J. Yi-gan san for treatment of borderline personality disorder: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 150-154
7. Miyaoka T., Furuya M., Yasuda H., Hayashida M., Inagaki T., and Horiguchi J. Yi-gan san for treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 32 (2008) 761-764
8. Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J. Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study. Clin Neuropharmacol in press.
9. Moja M.C., Milano E., Gasverde S., Gianelli M., and Giordana M.T. Olanzapine therapy in hallucinatory visions related to Bonnet syndrome. Neurol Sci 26 (2005) 168-170
10. Pauling M., and Mentrup H. Charles Bonnet syndrome: complete remission of complex visual hallucinations treated by gabapetin. J Neurol Neurosurg Psychiatry 70 (2001) 813-814
11. Rovner B.W. The Charles Bonnet syndrome: a review of recent research. Curr Opin Ophthalmol 17 (2006) 275-277
12. Shimada Y., Goto H., and Itoh T. Evaluation of the protective effects of alkaloids isolated from the hooks and stems of Uncaria sinesis on glutamate-induced neuronal death in cultured cerebellar granule cells from rats. J Pharm Pharmacol 51 (1999) 715-722
13. Teunisse R.J., Cruysberg J.R., Hoefnagels W.H., Verbeek A.L., and Zitman F.G. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 347 (1996) 794-797
14. Waragai M., Yamada T., and Matsuda H. Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative disease. J Neurol Sci 260 (2007) 57-64